Adam Komorowski

Assistant Professor (part-time)

McMaster University

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Adam Komorowski is an Assistant Professor (part-time) at McMaster University in Canada. His research areas include clinical trials and the impact of various treatments on infectious diseases, as evidenced by his recent articles on beta blockers in cancer survival, COVID-19 vaccine trials, and the effectiveness of treatments for Staphylococcus aureus bacteremia. Additionally, he has conducted systematic reviews analyzing diagnostic methods and trial methodologies in infectious diseases.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Gail M. Gauvreau

McMaster University

CANADA

View details

Dominik Mertz

Associate Professor

McMaster University

CANADA

View details

Anthony Bai

Assistant professor

Queen's University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adam Komorowski

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

The Impact of Beta Blockers on Survival in Cancer Patients: A Systematic Review and Meta-Analysis

AeroVax: study protocol for a randomised, double-blind, placebo-controlled phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans

Cerebrospinal fluid galactomannan detection for the diagnosis of central nervous system aspergillosis: a diagnostic test accuracy systematic review and meta-analysis

More Than a Decade Since the Latest CONSORT Non-inferiority Trials Extension: Do Infectious Diseases Trials Do Enough?

Verification, Analytical Sensitivity, Cost-effectiveness, and Comparison of 4 Candida auris Screening Methods

Evaluating in vivo effectiveness of sotrovimab for the treatment of Omicron subvariant BA.2 versus BA.1: a multicentre, retrospective cohort study

Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review

How Generalizable Are Randomized Controlled Trials (RCTs) in Staphylococcus aureus Bacteremia? A Description of the Mortality Gap Between RCTs and Observational Studies

Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review

What Is the Optimal Follow-up Length for Mortality in Staphylococcus aureus Bacteremia? Observations From a Systematic Review of Attributable Mortality

Collaborators (3)

Gail M. Gauvreau

Dominik Mertz

Anthony Bai

Make your next move.